Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
BörsenkürzelSTXS
Name des UnternehmensStereotaxis Inc
IPO-datumAug 12, 2004
CEOMr. David Leo Fischel
Anzahl der mitarbeiter139
WertpapierartOrdinary Share
GeschäftsjahresendeAug 12
Addresse710 N Tucker Blvd
StadtST. LOUIS
BörseNYSE American Consolidated
LandUnited States of America
Postleitzahl63101
Telefon13146786100
Websitehttps://www.stereotaxis.com/
BörsenkürzelSTXS
IPO-datumAug 12, 2004
CEOMr. David Leo Fischel
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten